RecruitingNot applicableNCT06512779
Developing a Treatment Clustering System for Obstructive Sleep Apnea Using Polysomnographic Physiological Signals
Studying ADULT syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cheng-Kung University Hospital
- Principal Investigator
- Ching-Hsia Hung, PhDNational Cheng Kung University
- Intervention
- Control Group(other)
- Enrollment
- 150 target
- Eligibility
- 20 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- National Cheng Kung University Hospital, Tainan, Taiwan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06512779 on ClinicalTrials.govOther trials for ADULT syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07237750iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight LossLiu Yan
- ACTIVE NOT RECRUITINGNANCT07258615Longitudinal Ultrasound Assessment of Diaphragmatic and Respiratory Muscle Function Following Respiratory Muscle Training in Frail Older AdultsUniversidad Francisco de Vitoria
- RECRUITINGNANCT07343206Early Norepinephrine Administration and Rapid Dose AdjustmentSiriraj Hospital
- RECRUITINGPHASE3NCT07225686Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure TherapyAmgen
- RECRUITINGPHASE3NCT07284381A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye DiseaseAbbVie
- RECRUITINGNANCT07303452Evaluation of the Restera™ Serene™ System in Adults With Obstructive Sleep ApneaRestera, Inc.
- RECRUITINGPHASE2NCT06982963Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac DiseaseForte Biosciences, Inc.
- RECRUITINGNCT07043166Cardiovascular-Kidney-Metabolic Syndrome in Shanghai ZicitizensShanghai Changzheng Hospital